TickerSpark Feed

OTLK coverage

Every article, report, and earnings note where OTLK appears.

OTLK insiders just bought $5.81 million. The dilution risk is still the trade

OTLK's $5.81 million insider buying is a real vote of confidence, but the company is still funding an approved product with fresh equity. A $55 million stock-and-warrant offering, a 600 million share authorization and ongoing losses keep dilution ahead of durable commercial proof.

Aug 19, 2026·2 MIN

Biotechnology Dilution FDA Approval

OpinionOTLK

OTLK's FDA win is now a dilution story

OTLK has a real FDA-approved product, but the shareholder-approved expansion to 600 million authorized shares makes dilution the dominant trade setup. The August offering shows that financing pressure survived the regulatory victory and is already reaching common holders.

Aug 17, 2026·2 MIN

Biotech FDA Approval Dilution

On-Demand Research

Want a deeper dive on OTLK?

Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.

Generate OTLK Report

For Active Investors

Stock research for every investor

Reports on any stock
Daily market intelligence
AI analyst in your pocket
Portfolio analysis tools

Get Full Access →

Cancel anytime

Today's Top MoverPSTG

▲9.14%

Pure Storage Inc. · $86.22

OTLK insiders just bought $5.81 million. The dilution risk is still the trade

OTLK's FDA win is now a dilution story

Want a deeper dive on OTLK?

A new stock idea, every evening.

Stock research for every investor